Cargando…
Measuring effectiveness of drugs in observational databanks: promises and perils
Observational databanks have inherent strengths and shortcomings. As in randomized controlled trials, poor design of these databanks can either exaggerate or reduce estimates of drug effectiveness and can limit generalizability. This commentary highlights selected aspects of study design, data colle...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC400435/ https://www.ncbi.nlm.nih.gov/pubmed/15059263 http://dx.doi.org/10.1186/ar1151 |